Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2001 1
2003 1
2007 2
2008 1
2009 3
2010 1
2011 2
2012 7
2013 9
2014 4
2015 4
2016 7
2017 10
2018 5
2019 5
2020 7
2021 5
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.
Saghari M, Gal P, Gilbert S, Yateman M, Porter-Brown B, Brennan N, Quaratino S, Wilson R, Grievink HW, Klaassen ES, Bergmann KR, Burggraaf J, van Doorn MBA, Powell J, Moerland M, Rissmann R. Saghari M, et al. Among authors: klaassen es. Clin Pharmacol Ther. 2022 May;111(5):1121-1132. doi: 10.1002/cpt.2539. Epub 2022 Mar 1. Clin Pharmacol Ther. 2022. PMID: 35092305 Free PMC article. Clinical Trial.
Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
Pagan L, Yfanti C, Rijneveld R, Todd M, Jongste P, Feijen JJ, Klaassen ES, Bouwes Bavinck JN, Struijk L, de Koning MNC, Prestegarden L, Niemeyer-van der Kolk T, van Poelgeest MIE, Rissmann R. Pagan L, et al. Among authors: klaassen es. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e773-e775. doi: 10.1111/jdv.18291. Epub 2022 Jun 14. J Eur Acad Dermatol Venereol. 2022. PMID: 35699238 Clinical Trial. No abstract available.
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.
Niemeyer-van der Kolk T, Assil S, Buters TP, Rijsbergen M, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, van Doorn MBA, Rissmann R, Moerland M. Niemeyer-van der Kolk T, et al. Among authors: klaassen es. Clin Transl Sci. 2020 May;13(3):573-579. doi: 10.1111/cts.12741. Epub 2020 Feb 13. Clin Transl Sci. 2020. PMID: 32043302 Free PMC article. Clinical Trial.
Renal Effects of Antisense-Mediated Inhibition of SGLT2.
van Meer L, Moerland M, van Dongen M, Goulouze B, de Kam M, Klaassen E, Cohen A, Burggraaf J. van Meer L, et al. Among authors: klaassen e. J Pharmacol Exp Ther. 2016 Nov;359(2):280-289. doi: 10.1124/jpet.116.233809. Epub 2016 Sep 7. J Pharmacol Exp Ther. 2016. PMID: 27605629 Clinical Trial.
A qualitative study on the perspectives of Turkish mothers and grandmothers in the Netherlands regarding the influence of grandmothers on health related practices in the first 1000 days of a child's life.
Bektas G, Boelsma F, Gündüz M, Klaassen EN, Seidell JC, Wesdorp CL, Dijkstra SC. Bektas G, et al. Among authors: klaassen en. BMC Public Health. 2022 Jul 16;22(1):1364. doi: 10.1186/s12889-022-13768-8. BMC Public Health. 2022. PMID: 35842646 Free PMC article.
Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers.
Dijkstra F, O'Donnell P, Klaassen E, Buhl D, Asgharnejad M, Rosen L, Zuiker R, van Gerven J, Jacobs G. Dijkstra F, et al. Among authors: klaassen e. Transl Psychiatry. 2022 Sep 24;12(1):408. doi: 10.1038/s41398-022-02148-w. Transl Psychiatry. 2022. PMID: 36153330 Free PMC article. Clinical Trial.
Identification of peripheral vascular function measures and circulating biomarkers of mitochondrial function in patients with mitochondrial disease.
van Kraaij SJW, Pereira DR, Smal B, Summo L, Konkel A, Lossie J, Busjahn A, Grammatopoulos TN, Klaassen E, Fischer R, Schunck WH, Gal P, Moerland M. van Kraaij SJW, et al. Among authors: klaassen e. Clin Transl Sci. 2023 Jul;16(7):1258-1271. doi: 10.1111/cts.13530. Epub 2023 May 12. Clin Transl Sci. 2023. PMID: 37177864 Free PMC article.
First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator.
van Kraaij SJW, Gal P, Borghans LGJM, Klaassen ES, Dijkstra F, Winrow C, Glasser C, Groeneveld GJ. van Kraaij SJW, et al. Among authors: klaassen es. Clin Transl Sci. 2023 Aug;16(8):1381-1395. doi: 10.1111/cts.13537. Epub 2023 May 3. Clin Transl Sci. 2023. PMID: 37118895 Free PMC article. Clinical Trial.
77 results